IRIX Form 4: CFO Romeo Dizon Purchases 1,000 Shares on 08/20/2025

Rhea-AI Filing Summary

Romeo R. Dizon, Chief Financial Officer of IRIDEX Corp (IRIX), reported two open-market purchases on 08/20/2025. He acquired 825 shares at $1.17 and 175 shares at $1.25, bringing his reported beneficial ownership to 44,745 shares following the transactions. The Form 4 was signed by an attorney-in-fact on 08/21/2025.

The filing lists Mr. Dizon's address in Mountain View, CA, and indicates the report was filed by one reporting person. No derivative transactions or additional explanations were provided in the filing.

Positive

• Insider purchases disclosed: CFO Romeo R. Dizon reported acquisitions of 825 shares at $1.17 and 175 shares at $1.25 on 08/20/2025.
• Timely compliance: Form 4 filed and signed by attorney-in-fact on 08/21/2025, indicating reporting obligations were met.

Negative

• None.

Insights

Financial Analyst

TL;DR: CFO made small open-market purchases totaling 1,000 shares at ~$1.20 average, increasing reported holdings to 44,745 shares.

These are straightforward, documented acquisitions by an officer recorded on a Form 4. The transactions consist of 825 shares at $1.17 and 175 shares at $1.25 executed on 08/20/2025. The total reported post-transaction beneficial ownership is 44,745 shares. From a financial-analysis perspective, the purchases are modest in size relative to the company and do not include derivatives or complex instruments. The filing contains no commentary on intent, planned future transactions, or material corporate events.

Corporate Governance Expert

TL;DR: Insider compliance appears routine: timely Form 4 reporting of small purchases by the CFO with attorney-in-fact signature.

The Form 4 shows the reporting obligations were met and the signature was executed by an attorney-in-fact on 08/21/2025. The transactions are coded as purchases and recorded as direct ownership. There are no amendments, no additional beneficial owners listed, and no disclosures of a trading plan or other arrangements within this filing. For governance review, the filing contains the essential required elements and no irregularities are evident from the document alone.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dizon Romeo R

(Last) (First) (Middle)

1212 TERRA BELLA AVENUE

(Street)

MOUNTAIN VIEW CA 94043

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IRIDEX CORP [ IRIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/20/2025		P		825	A	$1.17	44,570	D
Common Stock	08/20/2025		P		175	A	$1.25	44,745	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Nilo De Castro, Attorney-in-fact for Romeo R. Dizon	08/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did IRIX CFO Romeo R. Dizon report on Form 4?

He reported two purchases on 08/20/2025: 825 shares at $1.17 and 175 shares at $1.25, reported beneficial ownership 44,745 shares.

When were the reported IRIX transactions executed and filed?

Executed: 08/20/2025. Form signed: 08/21/2025 by an attorney-in-fact for Romeo R. Dizon.

Do the Form 4 filings include any derivative or option transactions for IRIX?

No. Table II (derivative securities) contains no reported transactions or amounts in this filing.

Did the filing indicate the purchases were part of a Rule 10b5-1 plan?

No. The filing does not include a checked indication or explanation that transactions were pursuant to a Rule 10b5-1 plan.

Who filed the Form 4 for Romeo R. Dizon?

The form was filed by one reporting person and signed by /s/ Nilo De Castro, attorney-in-fact for Romeo R. Dizon.